Controlled release hydrocodone formulations
First Claim
Patent Images
1. A solid oral controlled-release dosage comprising hydrocodone or a pharmaceutically acceptable salt thereof and at least one polymer hydrogel, the dosage form, after administration to a human subject, providing a C24/Cmax hydrocodone ratio of from about 0.55 to about 1.0, whereinthe dosage form is a tablet,the amount of hydrocodone in the dosage form is from about 0.5 mg to about 1250 mg, andthe hydrocodone or pharmaceutically acceptable salt thereof is the only active agent in the dosage form.
1 Assignment
0 Petitions
Accused Products
Abstract
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.
368 Citations
30 Claims
-
1. A solid oral controlled-release dosage comprising hydrocodone or a pharmaceutically acceptable salt thereof and at least one polymer hydrogel, the dosage form, after administration to a human subject, providing a C24/Cmax hydrocodone ratio of from about 0.55 to about 1.0, wherein
the dosage form is a tablet, the amount of hydrocodone in the dosage form is from about 0.5 mg to about 1250 mg, and the hydrocodone or pharmaceutically acceptable salt thereof is the only active agent in the dosage form.
-
12. A solid oral controlled-release dosage form comprising hydrocodone or a pharmaceutically acceptable salt thereof and at least one polymer hydrogel, the dosage form, after administration to human subjects, providing a mean C24/Cmax hydrocodone ratio of from about 0.55 to about 1.0, wherein
the dosage form is a tablet, the amount of hydrocodone in the dosage form is from about 0.5 mg to about 1250 mg, and the hydrocodone or pharmaceutically acceptable salt thereof is the only active agent in the dosage form.
-
21. A solid oral controlled-release dosage form comprising a bitartrate salt of hydrocodone and at least one polymer hydrogel, wherein
the dosage form, after administration to a human subject, provides a W50 of hydrocodone of between 4 and 22 hours and a therapeutic effect for about 24 hours, the dosage form is a compressed tablet, the amount of hydrocodone in the dosage form is from about 0.5 mg to about 1250 mg, and the bitartrate salt of hydrocodone is the only active agent in the dosage form.
-
28. A solid oral controlled-release dosage form comprising a bitartrate salt of hydrocodone and at least one polymer hydrogel, wherein
the dosage form, after administration to human subjects, provides a mean W50 of hydrocodone of between 4 and 22 hours and a therapeutic effect for about 24 hours, wherein the dosage form is a compressed tablet, the amount of hydrocodone in the dosage form is from about 0.5 mg to about 1250 mg, and the bitartrate salt of hydrocodone is the only active agent in the dosage form.
Specification